Xtant Medical Holdings Statistics
Total Valuation
XTNT has a market cap or net worth of $117.39 million. The enterprise value is $135.03 million.
| Market Cap | 117.39M |
| Enterprise Value | 135.03M |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, before market open.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
XTNT has 130.22 million shares outstanding. The number of shares has increased by 34.76% in one year.
| Shares Outstanding | 130.22M |
| Shares Change (YoY) | +34.76% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 8.30% |
| Owned by Institutions (%) | 69.27% |
| Float | 39.72M |
Valuation Ratios
The trailing PE ratio is 91.77.
| PE Ratio | 91.77 |
| Forward PE | n/a |
| PS Ratio | 1.29 |
| Forward PS | 1.00 |
| PB Ratio | 2.29 |
| P/FCF Ratio | n/a |
| PEG Ratio | -0.03 |
Enterprise Valuation
| EV / Earnings | 204.59 |
| EV / Sales | 1.48 |
| EV / EBITDA | 26.61 |
| EV / EBIT | 71.03 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.46.
| Current Ratio | 2.82 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 4.64 |
| Debt / FCF | n/a |
| Interest Coverage | 0.65 |
Financial Efficiency
Return on equity (ROE) is 1.60% and return on invested capital (ROIC) is -13.56%.
| Return on Equity (ROE) | 1.60% |
| Return on Assets (ROA) | 0.80% |
| Return on Capital (ROIC) | -13.56% |
| Revenue Per Employee | $441,077 |
| Profits Per Employee | $3,188 |
| Employee Count | 207 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 1.32 |
Taxes
| Income Tax | -1.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.44% in the last 52 weeks. The beta is 0.22, so XTNT's price volatility has been lower than the market average.
| Beta (1Y) | 0.22 |
| 52-Week Price Change | +50.44% |
| 50-Day Moving Average | 1.02 |
| 200-Day Moving Average | 1.10 |
| Relative Strength Index (RSI) | 45.93 |
| Average Volume (30 Days) | 156,079 |
Short Selling Information
The latest short interest is 260,861, so 0.20% of the outstanding shares have been sold short.
| Short Interest | 260,861 |
| Short Previous Month | 192,468 |
| Short % of Shares Out | 0.20% |
| Short % of Float | 0.66% |
| Short Ratio (days to cover) | 0.93 |
Income Statement
In the last 12 months, XTNT had revenue of $91.30 million and earned $660,000 in profits. Earnings per share was $0.01.
| Revenue | 91.30M |
| Gross Profit | 55.47M |
| Operating Income | -10.16M |
| Pretax Income | -1.04M |
| Net Income | 660,000 |
| EBITDA | 5.08M |
| EBIT | 1.90M |
| Earnings Per Share (EPS) | $0.01 |
Balance Sheet
The company has $5.92 million in cash and $23.56 million in debt, giving a net cash position of -$17.64 million or -$0.14 per share.
| Cash & Cash Equivalents | 5.92M |
| Total Debt | 23.56M |
| Net Cash | -17.64M |
| Net Cash Per Share | -$0.14 |
| Equity / Book Value | 51.35M |
| Book Value Per Share | 0.39 |
| Working Capital | 41.88M |
Cash Flow
In the last 12 months, operating cash flow was -$9.52 million and capital expenditures -$1.28 million, giving a free cash flow of -$10.80 million.
| Operating Cash Flow | -9.52M |
| Capital Expenditures | -1.28M |
| Free Cash Flow | -10.80M |
| FCF Per Share | -$0.09 |
Margins
Gross margin is 60.75%, with operating and profit margins of -11.13% and 0.72%.
| Gross Margin | 60.75% |
| Operating Margin | -11.13% |
| Pretax Margin | -1.14% |
| Profit Margin | 0.72% |
| EBITDA Margin | 5.56% |
| EBIT Margin | 2.08% |
| FCF Margin | -11.82% |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.76% |
| Shareholder Yield | -34.76% |
| Earnings Yield | 0.56% |
| FCF Yield | -9.20% |
Analyst Forecast
The average price target for XTNT is $1.60, which is 77.48% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.60 |
| Price Target Difference | 77.48% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 14, 2018. It was a reverse split with a ratio of 1:12.
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
XTNT has an Altman Z-Score of -0.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.37 |
| Piotroski F-Score | 4 |